Steven St. Gallay

Person

Nottingham, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Sulfonamide derivates as NLRP3 inhibitors
- Patent number 12,168,653
- Issue date Dec 17, 2024
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonyl acetamides as NLRP3 inhibitors
- Patent number 12,030,879
- Issue date Jul 9, 2024
- Inflazome Limited
- Matthew Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonamide carboxamide compounds
- Patent number 12,012,392
- Issue date Jun 18, 2024
- Inflazome Limited
- Matthew Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonamide carboxamide compounds
- Patent number 11,981,667
- Issue date May 14, 2024
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
- Patent number 11,926,600
- Issue date Mar 12, 2024
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide carboxamide compounds
- Patent number 11,773,058
- Issue date Oct 3, 2023
- Inflazome Limited
- David Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nicotinamide RIPK1 inhibitors
- Patent number 11,767,310
- Issue date Sep 26, 2023
- AbbVie Inc.
- Kevin Patrick Cusack
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 11,623,922
- Issue date Apr 11, 2023
- Inflazome Limited
- David Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
- Patent number 11,613,542
- Issue date Mar 28, 2023
- Inflazome Limited
- Matthew Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
- Patent number 11,542,255
- Issue date Jan 3, 2023
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide carboxamide compounds
- Patent number 11,518,739
- Issue date Dec 6, 2022
- Inflazome Limited
- David Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide carboxamide compounds
- Patent number 11,465,992
- Issue date Oct 11, 2022
- Inflazome Limited
- Matthew Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
- Patent number 11,370,776
- Issue date Jun 28, 2022
- Inflazome Limited
- Matthew Cooper
- G01 - MEASURING TESTING
Information Patent Grant
Human NESP55 polypeptides, polynucleotides and uses thereof
- Patent number 6,608,025
- Issue date Aug 19, 2003
- Knoll, AG
- Douglas Fraser
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20250115591
- Publication date Apr 10, 2025
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NICOTINAMIDE RIPK1 INHIBITORS
- Publication number 20240360099
- Publication date Oct 31, 2024
- ABBVIE INC.
- Kevin Patrick Cusack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NICOTINAMIDE RIPK1 INHIBITORS
- Publication number 20230127127
- Publication date Apr 27, 2023
- ABBVIE INC.
- Kevin Patrick Cusack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20230037255
- Publication date Feb 2, 2023
- INFLAZOME LIMITED
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20220289766
- Publication date Sep 15, 2022
- INFLAZOME LIMITED
- Matthew COOPER
- G01 - MEASURING TESTING
Information Patent Application
SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS
- Publication number 20210130359
- Publication date May 6, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS
- Publication number 20210130329
- Publication date May 6, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20210122739
- Publication date Apr 29, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS
- Publication number 20210122716
- Publication date Apr 29, 2021
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20210002274
- Publication date Jan 7, 2021
- Inflazome Limited
- Matthew COOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFONAMIDE DERIVATES AS NLRP3 INHIBITORS
- Publication number 20200407340
- Publication date Dec 31, 2020
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20200361895
- Publication date Nov 19, 2020
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20200331850
- Publication date Oct 22, 2020
- Inflazome Limited
- David MILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20200331886
- Publication date Oct 22, 2020
- Inflazome Limited
- David MILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20200317637
- Publication date Oct 8, 2020
- Matthew COOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20200291003
- Publication date Sep 17, 2020
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS
- Publication number 20200270227
- Publication date Aug 27, 2020
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
- Publication number 20200216389
- Publication date Jul 9, 2020
- Inflazome Limited
- David MILLER
- C07 - ORGANIC CHEMISTRY

Steven St. Gallay

Person

Patents Grantslast 30 patents

Sulfonamide derivates as NLRP3 inhibitors

Sulfonyl acetamides as NLRP3 inhibitors

Sulfonamide carboxamide compounds

Sulfonamide carboxamide compounds

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Sulfonamide carboxamide compounds

Nicotinamide RIPK1 inhibitors

Compounds

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Sulfonamide carboxamide compounds

Sulfonamide carboxamide compounds

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Human NESP55 polypeptides, polynucleotides and uses thereof

Patents Applicationslast 30 patents

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

NICOTINAMIDE RIPK1 INHIBITORS

NICOTINAMIDE RIPK1 INHIBITORS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS

SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

NOVEL COMPOUNDS

SULFONAMIDE DERIVATES AS NLRP3 INHIBITORS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

NOVEL COMPOUNDS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS